F. Visentini

发表

Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.

A. Capelli, M. Mor, M. Corsi, 2017, Journal of medicinal chemistry.

1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.

C. Heidbreder, L. Castelletti, P. Cavallini, 2016, Bioorganic & medicinal chemistry.

In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)

A. Capelli, M. Corsi, L. Gordon, 2011, Neuropharmacology.

Azabicyclo[3.1.0]hexane‐1‐carbohydrazides as Potent and Selective GHSR1a Ligands Presenting a Specific in vivo Behavior

S. Bromidge, S. Melotto, M. Corsi, 2011, ChemMedChem.

Biodiversity amongst cultivable polycyclic aromatic hydrocarbon-transforming bacteria isolated from an abandoned industrial site

G. Vallini, Chiara Zocca, F. Visentini, 2004 .

Biodiversity amongst cultivable polycyclic aromatic hydrocarbon-transforming bacteria isolated from an abandoned industrial site.

G. Vallini, S. Di Gregorio, Chiara Zocca, 2004, FEMS microbiology letters.

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.

K. Read, G. Tedesco, D. Minick, 2010, Journal of medicinal chemistry.

1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.

M. Roščić, A. Worby, F. Micheli, 2011, Bioorganic & medicinal chemistry.

6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.

K. Read, G. Tedesco, R. Carletti, 2010, Journal of medicinal chemistry.